(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) dropped 8.26% to $5.16 at 16:01 EST on Wednesday, following the last session’s downward trend. NASDAQ is falling 0.17% to $12,060.34, following the last session’s downward trend. This seems, up until now, a somewhat bearish trend exchanging session today.

Pacific Biosciences of California’s last close was $5.63, 84.52% below its 52-week high of $36.36.

Volume

Today’s last reported volume for Pacific Biosciences of California is 5874351 which is 9.98% below its average volume of 6526273.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the ongoing quarter and 30.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.49%, a negative 1.01%, and a positive 5.81%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 6.28% (last week), 7.22% (last month), and 5.81% (last quarter), respectively.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.16 at 16:01 EST, way under its 52-week high of $36.36 and way higher than its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $7.39 and way below its 200-day moving average of $17.48.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here